NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?
NewAmsterdam Pharma Ownership Summary
NewAmsterdam Pharma is owned by 10.30% institutional investors, 0.47% insiders, and 89.24% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 14.84% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 7.48% of its assets in NewAmsterdam Pharma shares.
NAMS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NewAmsterdam Pharma | 10.30% | 0.47% | 89.24% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 16.70M | 14.84% | $475.00M |
| Bain capital life sciences investors | 10.72M | 9.53% | $304.85M |
| Ra capital management | 10.14M | 9.01% | $288.35M |
| Capital world investors | 9.98M | 8.39% | $350.24M |
| Fcpm iii services b.v. | 9.21M | 8.19% | $262.00M |
| Viking global investors lp | 6.48M | 5.76% | $184.16M |
| Fmr | 5.54M | 4.92% | $157.42M |
| Deerfield management company, l.p. (series c) | 4.27M | 3.79% | $121.34M |
| Wellington management group llp | 4.02M | 3.57% | $114.33M |
| Jennison associates | 3.49M | 2.93% | $122.40M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.21M | 52.36% | $262.00M |
| Bain capital life sciences investors | 10.72M | 20.23% | $304.85M |
| Frazier life sciences management | 16.70M | 14.23% | $475.00M |
| Medicxi ventures management (jersey) | 2.87M | 12.06% | $100.66M |
| Cormorant asset management, lp | 2.17M | 4.27% | $61.86M |
| Ra capital management | 10.14M | 3.55% | $288.35M |
| First turn management | 716.97K | 3.06% | $20.39M |
| Decheng capital | 592.06K | 2.79% | $20.77M |
| Healthinvest partners ab | 197.04K | 2.21% | $6.91M |
| Deerfield management company, l.p. (series c) | 4.27M | 1.85% | $121.34M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 5.54M | 0.01% | 3.63M |
| Duquesne family office | 1.92M | 1.35% | 1.09M |
| Goldman sachs group | 1.73M | 0.01% | 845.11K |
| Wellington management group llp | 4.02M | 0.02% | 697.13K |
| Ensign peak advisors | 549.51K | 0.03% | 549.51K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fcpm iii services b.v. | 9.21M | 52.36% | -1.42M |
| Morgan stanley | 532.80K | 0.00% | -964.68K |
| Deerfield management company, l.p. (series c) | 4.27M | 1.85% | -849.26K |
| Siren | - | - | -765.71K |
| Woodline partners lp | 1.16M | 0.15% | -739.33K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ensign peak advisors | 549.51K | 0.03% | 549.51K | $19.28M |
| Jane street group | 421.49K | 0.00% | 421.49K | $14.79M |
| Lord, abbett | 200.64K | 0.02% | 200.64K | $7.04M |
| Axa investment managers | 196.78K | 0.02% | 196.78K | $5.60M |
| Moody aldrich partners | 143.55K | 0.94% | 143.55K | $5.04M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -13.00 |
| Coldstream capital management | -24.00 |
| Clearstead advisors | -88.00 |
| Assetmark | -96.00 |
| Advisor group | -142.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 55 | -62.07% | 12,251,519 | -89.84% | 10 | 0.09% | 32 | -58.44% | 10 | -72.97% |
| Sep 30, 2025 | 43 | -66.67% | 10,963,801 | -90.21% | 9 | 0.10% | 20 | -75.61% | 10 | -62.96% |
| Jun 30, 2025 | 135 | 3.05% | 116,309,195 | 16.74% | 103 | 1.40% | 85 | 11.84% | 28 | -9.68% |
| Mar 31, 2025 | 135 | -3.57% | 111,187,228 | 12.82% | 95 | 0.89% | 78 | -11.36% | 33 | 6.45% |
| Dec 31, 2024 | 33 | -67.96% | 21,547,862 | -71.71% | 22 | 0.35% | 19 | -71.64% | 8 | -52.94% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 8.60M | 7.48% | - |
| Vanguard Health Care Inv | 3.67M | 3.19% | 823.72K |
| Polar Capital Biotech S Inc | 2.63M | 2.28% | - |
| Capital Group Global Equity Canada F | 2.52M | 2.19% | - |
| Fidelity Contrafund | 986.17K | 0.86% | - |
| PGIM Jennison Small Company A | 966.54K | 0.84% | - |
| Jennison SMid Cap Core Equity | 966.54K | 0.84% | -119.37K |
| AB Small Cap Growth A | 686.06K | 0.61% | 32.56K |
| Pictet-Global Megatrend Sel I USD | 682.29K | 0.61% | 10.43K |
| Candriam Eqs L Biotech C USD Cap | 684.30K | 0.60% | 13.07K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Davidson Michael H. | Chief Executive Officer | Sell | $14.75M |
| Feb 25, 2026 | Davidson Michael H. | Chief Executive Officer | Sell | $1.63M |
| Feb 26, 2026 | Davidson Michael H. | Chief Executive Officer | Sell | $5.56M |
| Feb 24, 2026 | Davidson Michael H. | Chief Executive Officer | Sell | $2.22M |
| Feb 25, 2026 | Davidson Michael H. | Chief Executive Officer | Sell | $375.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 25 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | 3 | 10 |
| 2025 Q2 | 3 | 5 |
| 2025 Q1 | 2 | 17 |
NAMS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools